Literature DB >> 11073748

Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.

J M Mylotte1, A Tayara.   

Abstract

We performed a retrospective study of a large cohort of patients who had episodes of Staphylococcus aureus bacteremia (SAB) from January 1995 through February 1999 at 1 medical center to identify predictors of 30-day mortality in SAB. Among 293 patients with episodes of SAB, 68 died (23.2%) within 30 days of onset. There was no significant difference in 30-day mortality associated with treatment with vancomycin, a beta-lactam, or a miscellaneous group of antimicrobial agents (P=.180). By logistic regression, an acute physiology score (a component of the acute physiology and chronic health evaluation [APACHE III]) >60 at onset of SAB was the most important predictor of 30-day mortality (odds ratio [OR], 15.7). Other significant predictors were lung (OR, 5.8) or unknown (OR, 4.1) focus of SAB, age > or =65 years (OR, 2.0), and diabetes mellitus (OR, 2.4). Future investigators of SAB should take into consideration acute severity of illness at onset as well as other factors when evaluating or comparing outcomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073748     DOI: 10.1086/317421

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  59 in total

1.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

2.  The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-14       Impact factor: 3.267

3.  Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia.

Authors:  F Hanses; C Spaeth; B P Ehrenstein; H-J Linde; J Schölmerich; B Salzberger
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

4.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

5.  Outcome for invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; E Gustafsson; R Andersson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

6.  Persistent bacteremia in the absence of defined intravascular foci: clinical significance and risk factors.

Authors:  M Y Chowers; B Gottesman; M Paul; M Weinberger; S Pitlik; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-25       Impact factor: 3.267

7.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

8.  Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.

Authors:  Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; George Sakoulas; Eli N Perencevich
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

9.  A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.

Authors:  Hee Jung Yoon; Jun Yong Choi; Chang Oh Kim; June Myung Kim; Young Goo Song
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

10.  Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia.

Authors:  James Price; Gillian Baker; Ian Heath; Karen Walker-Bone; Marc Cubbon; Sally Curtis; Mark C Enright; Jodi Lindsay; John Paul; Martin Llewelyn
Journal:  Int J Microbiol       Date:  2010-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.